Crisis and Opportunities of Post-Pandemic Clinical Trials in Taiwan
| 活動名稱 | Crisis and Opportunities of Post-Pandemic Clinical Trials in Taiwan |
|---|---|
| 報名期間 | 2021.07.28 至 2022.04.18 |
| 活動時間 | 2022.04.19(二) 09:00 - 10:00 |
| 活動地點 | Webinar |
| 辦理單位 | Society for Clinical Research Sites、中國醫藥大學附設醫院臨床試驗中心 |
| 連絡電話 | 04-2205-2121 ext.1474 |
| 課程費用 | 免費 |
| 報名名額 | 1000人 |
| 承辦人 | 汪庭羽 |
| 承辦人信箱 | a32143@mail.cmuh.org.tw |
活動內容
Society for Clinical Research Sites(簡稱SCRS)為提供全球臨床研究機構發聲管道，建立一個臨床試驗執行機構(Site)、受託研究機構(CRO)及藥廠(Sponsor)之間積極合作與交流的平台。
本院臨床試驗中心許重義教授自105年起擔任SCRS台灣大使，本次協助邀請美商默沙東藥廠「黃麗榕Keris」臨床試驗執行總監 參與2022 SCRS Taiwan online webinar，將於台灣時間4月19日(二)上午9:00~10:00以「Crisis and Opportunities of Post-Pandemic Clinical Trials in Taiwan」為主題進行全球線上直播會議。
★機會難得，誠摯邀請有興趣者踴躍註冊參加！★
【內容簡介】
This webinar will address Taiwanese post-pandemic opportunities illustrated through the study flow from site selection to the end of study. Under different study phases, we will identify challenges and opportunities post-COVID-19. The session will conclude with some recommendations from sponsors’ points of view to build a better clinical trial environment in Taiwan and to encourage everyone to think ahead and prepare for the future. Join us for a journey through the study flow:
1. Feasibility to Site Ready
2. Ongoing phase: Subject enrollment & Monitoring
3. Quality Control: Oversight Process & Audit/ Inspectio